These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2090485)
1. Subclinical alveolitis in immunological systemic disorders. Transition between health and disease? Wallaert B; Dugas M; Dansin E; Perez T; Marquette CH; Ramon P; Tonnel AB; Voisin C Eur Respir J; 1990 Nov; 3(10):1206-16. PubMed ID: 2090485 [TBL] [Abstract][Full Text] [Related]
2. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625 [TBL] [Abstract][Full Text] [Related]
3. [Latent alveolitis in systemic disease. The transition between the normal and the pathological]. Wallaert B; Dugas M; Tonnel AB; Voisin C Rev Mal Respir; 1990; 7(1):17-25. PubMed ID: 2251429 [TBL] [Abstract][Full Text] [Related]
4. Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage. Manganelli P; Salaffi F; Pesci A Semin Arthritis Rheum; 1997 Apr; 26(5):740-54. PubMed ID: 9144850 [TBL] [Abstract][Full Text] [Related]
5. Subclinical alveolitis in immunologic systemic disorders. Wallaert B Lung; 1990; 168 Suppl():974-83. PubMed ID: 2117218 [TBL] [Abstract][Full Text] [Related]
6. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease]. Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098 [TBL] [Abstract][Full Text] [Related]
8. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Hunninghake GW Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889 [TBL] [Abstract][Full Text] [Related]
9. From subclinical alveolitis to granulomatosis. Sequential evaluation of pulmonary involvement in extrathoracic sarcoidosis. Dugas M; Wallaert B; Tonnel AB; Voisin C Chest; 1989 Oct; 96(4):931-3. PubMed ID: 2791690 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-/polymyositis and systemic sclerosis. Kumánovics G; Magyarlaki T; Komócsi A; Szekeres G; Czirják L Rheumatol Int; 2003 Jan; 23(1):6-10. PubMed ID: 12548435 [TBL] [Abstract][Full Text] [Related]
11. [Airway and alveolar inflammation assessments with bronchoalveolar lavage in various interstitial lung disorders]. Matsuda K; Satoh M; Kawanami O Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):827-34. PubMed ID: 1630046 [TBL] [Abstract][Full Text] [Related]
12. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage. Witt C; Dörner T; Hiepe F; Borges AC; Fietze I; Baumann G Lupus; 1996 Dec; 5(6):606-12. PubMed ID: 9116705 [TBL] [Abstract][Full Text] [Related]
14. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases. Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401 [TBL] [Abstract][Full Text] [Related]
15. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. Robinson BW; McLemore TL; Crystal RG J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary involvement in sclerodermia]. Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431 [TBL] [Abstract][Full Text] [Related]
17. Proliferating alveolar macrophages in BAL and lung function changes in interstitial lung disease. Pforte A; Gerth C; Voss A; Beer B; Häussinger K; Jütting U; Burger G; Ziegler-Heitbrock HW Eur Respir J; 1993 Jul; 6(7):951-5. PubMed ID: 8370443 [TBL] [Abstract][Full Text] [Related]
18. [Demonstration of subclinical pulmonary alveolitis in spondylarthropathies]. Jeandel P; Bonnet D; Chouc PY; Molinier S; Raphenon G; Martet G; Merouze F; de Muizon H Rev Rhum Ed Fr; 1994 May; 61(5):301-9. PubMed ID: 7812284 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of interstitial lung disease in mixed connective tissue disease]. Colin G; Nunes H; Hatron PY; Cadranel J; Tillie I; Wallaert B Rev Mal Respir; 2010 Mar; 27(3):238-46. PubMed ID: 20359616 [TBL] [Abstract][Full Text] [Related]
20. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment. Ceuppens JL; Lacquet LM; Mariën G; Demedts M; van den Eeckhout A; Stevens E Am Rev Respir Dis; 1984 Apr; 129(4):563-8. PubMed ID: 6231871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]